3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Classical hematology
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Rectal Neoplasms
1
Pain, Postoperative
1
Neoplasms
1
Mucositis
1
Ileus
1
Head and Neck Neoplasms
1
Dyspnea, Paroxysmal
1
Dyspnea
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Constipation
1
Colonic Neoplasms
1
Agnosia
1
Abnormalities, Radiation-Induced
1
Interventions
Resistance Training
4
Nutrition Assessment
4
naloxegol
3
Surveys and Questionnaires
3
Exercise
3
alvimopan
2
Therapeutics
2
Psychiatric Rehabilitation
2
Oxygen
2
Nutritional Status
2
Mouthwashes
2
Morphine
2
Ketamine
2
Interviews as Topic
2
Fibroblast Growth Factor 7
2
Counseling
2
semaglutide
1
naldemedine
1
methylnaltrexone
1
ma zi ren wan
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
calcium phosphate
1
auricularum
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Weights and Measures
1
Walking
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Fentanyl
×
Other
×
Clear all
NCT04635852
2020-11-19
EFFENDYS
University of Cologne
Phase 2
Completed
10 enrolled